Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current landscape and future directions of bispecific antibodies in cancer immunotherapy
Jing Wei, Yueyao Yang, Gang Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis
Gemma Reynolds, Edward R. Scheffer Cliff, Ghulam Rehman Mohyuddin, et al.
Blood Advances (2023) Vol. 7, Iss. 19, pp. 5898-5903
Open Access | Times Cited: 45
Radiotherapy and immunology
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 27
Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives
Iman Abou Dalle, Rémy Duléry, Nour Moukalled, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 19
The role of microRNAs in the gastric cancer tumor microenvironment
Xianzhe Yu, Yin Zhang, Fengming Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
Therapeutic Antibodies in Medicine
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 29
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
Peng Ouyang, Lijuan Wang, Jianlong Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Design and engineering of bispecific antibodies: insights and practical considerations
Andreas V. Madsen, Lasse Ebdrup Pedersen, Peter Kristensen, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 15
Bispecific antibodies: advancing precision oncology
M. Zurita Herrera, G. Pretelli, Jayesh Desai, et al.
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 893-919
Open Access | Times Cited: 15
Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment
Tine Logghe, Eke van Zwol, Benoît Immordino, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 505-505
Open Access | Times Cited: 10
Elranatamab: First Approval
Sohita Dhillon
Drugs (2023) Vol. 83, Iss. 17, pp. 1621-1627
Closed Access | Times Cited: 18
Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
Xiaojing Qin, Wenjing Ning, Han Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2361-2377
Open Access | Times Cited: 8
A new era of antibody discovery: an in-depth review of AI-driven approaches
Jin Cheng, Tianjian Liang, Xiang‐Qun Xie, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103984-103984
Closed Access | Times Cited: 6
Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy
Fakhrossadat Emami, Ramesh Duwa, Asmita Banstola, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115023-115023
Open Access | Times Cited: 14
Development of bispecific T cell engagers: harnessing quantitative systems pharmacology
Timothy Qi, Xiaozhi Liao, Yanguang Cao
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 12, pp. 880-890
Open Access | Times Cited: 14
Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment
Justyn Fine, Bunyarit Meksiriporn, Jiacheng Tan, et al.
Annual Review of Chemical and Biomolecular Engineering (2024) Vol. 15, Iss. 1, pp. 105-138
Closed Access | Times Cited: 5
A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody–Drug Conjugates
Nadine Barron, Stephan Dickgießer, Markus Fleischer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2097-2097
Open Access | Times Cited: 5
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 5
Tailoring Treatment in Cardiovascular Diseases: The Role of Targeted Therapies
Razan Dankar, Jad Wehbi, Marwan M. Refaat
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 461-461
Open Access | Times Cited: 4
Affordable mRNA Novel Proteins, Recombinant Protein Conversions, and Biosimilars—Advice to Developers and Regulatory Agencies
Sarfaraz K. Niazi
Biomedicines (2025) Vol. 13, Iss. 1, pp. 97-97
Open Access
Avances en inmunoterapia para leucemia linfocítica aguda: integración de terapias con células car-T y otras estrategias inmunológicas
Vladimir Moreta, Daniela Alexandra Rosero Freire
Bionatura journal : (2025) Vol. 2, Iss. 1, pp. 1-23
Closed Access
Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies
Han‐ul Kim, Young Kwan Kim
Han-guk hyeonmigyeong hakoeji/Applied microscopy (2025) Vol. 55, Iss. 1
Open Access
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Masaud Shah, Muhammad Hussain, Hyun Goo Woo
Genomics & Informatics (2025) Vol. 23, Iss. 1
Open Access
Improving Treatment Options for Patients with Double Refractory CLL
Ryan Jacobs, William Wierda
Cancers (2025) Vol. 17, Iss. 3, pp. 430-430
Open Access
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity
Jérémy Loyau, Thierry Monney, Marco Montefiori, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top